Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BHA issues warning over products containing altrenogest
BHA is carrying out further work to understand the implications of this issue in Europe. 

Trace levels of anabolic steroids found in some products 

The British Horseracing Authority (BHA) is making vets and trainers aware of an international issue regarding products that contain altrenogest.

Trace levels of the anabolic steroids trenbolone and/or trendione have been detected in products containing altrenogest, which is commonly referred to by its trade name, Regumate.

Racing Victoria (Australia) has advised trainers to immediately cease using such products and further investigations are now underway.

In the UK, one such product is licensed for use in horses - Regumate Equine 2.2mg/ml Oral Solution for Horses (MSD Animal Health).

After discussions with the European manufacturer, BHA said it can confirm that the product distributed in the UK is reportedly sourced from a separate location to the products that are currently under investigation.

However, in light of the international situation, BHA is strongly advising trainers to be cautious if using altrenogest in racing thoroughbreds.

The BHA published Detection Time for altrenogest is 288 hours (15 days). In contrast, a 24-hour withdrawal from racing is recommended in Australia for mares and fillies receiving oral altrenogest.

BHA is carrying out further work to understand the implications of this issue in Europe.  

 

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.